Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2009
11/18/2009CN100560092C Externally used traditional Chinese medicine for treating hepatitis B and hepatic ascites
11/18/2009CN100560090C Methods of acquiring total tanshinone and total phenolic acid
11/18/2009CN100560088C Use of sophora alapecuroides in preparing medicament for treating zoster
11/18/2009CN100560081C Method for extracting flavonoids from the waxberry core
11/18/2009CN100560077C Pharmaceutical composition and its preparation method and uses
11/18/2009CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/18/2009CN100560062C Clindamycin phosphate freeze-dried powder needle and preparation thereof
11/17/2009USRE40987 for the treatment and prevention of AIDS
11/17/2009US7619065 Cystine-knot fold protein
11/17/2009US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009US7618986 Method of treating latent tuberculosis
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618783 Anthrax specific antibodies
11/17/2009US7618658 applying a Sasa plant extract on skin for treating Propionibacterium infections
11/17/2009US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009US7618641 Functionally reconstituted viral membranes containing adjuvant
11/17/2009US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009US7618625 Compositions comprising large and small binding fragments of antibodies against the same toxin
11/17/2009US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/17/2009CA2510949C Polymorph of ritonavir
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2444551C Microprojection array immunization patch and method
11/17/2009CA2444501C Phenylindoles for the treatment of hiv
11/17/2009CA2411368C Therapeutic combinations of fatty acids
11/17/2009CA2399299C Compounds with chelation affinity and selectivity for first transition series elements and their use
11/17/2009CA2396958C Pet food composition for treating gastric helicobacter-like organisms (ghlos) in pets
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2383364C Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/17/2009CA2382569C Super-oxidized water, preparation and use therefor as sterilizers and medicaments
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2372691C Antifungal ethers
11/17/2009CA2366897C Immunomodulatory compositions and methods of use thereof
11/17/2009CA2318536C Method of and compositions for immunization with the pseudomonas v antigen
11/17/2009CA2301739C Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/17/2009CA2211459C A method for making heteromultimeric polypeptides
11/17/2009CA2206515C Identification of genes which allow a microorganism to adapt to a particular environment
11/17/2009CA2166079C Chemically modified oligonucleotide for site-directed mutagenesis
11/17/2009CA2116327C Method and compositions for cellular reprogramming
11/12/2009WO2009137737A2 Anti-bacterial activity of 9-hydroxy derivatives of 6, 11-bicyclolides
11/12/2009WO2009137632A2 Hiv immunogen and method of making and using same
11/12/2009WO2009137611A2 Treatment of pulmonary fungal infection with voriconazole via inhalation
11/12/2009WO2009137532A1 Antiviral cell penetrating peptides
11/12/2009WO2009137500A1 6-substituted benzofuran compounds to treat infection with hepatitis c virus
11/12/2009WO2009137493A1 2-substituted benzofuran compounds to treat infection with hepatitis c virus
11/12/2009WO2009137454A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
11/12/2009WO2009137380A1 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
11/12/2009WO2009137133A2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
11/12/2009WO2009136979A2 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009136379A1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
11/12/2009WO2009136214A1 Combination compositions comprising antimycotic agents and statins and the use thereof
11/12/2009WO2009136086A2 Method of screening for antitubercular compounds
11/12/2009WO2009135880A1 Cistus extract containing enriched secondary plant ingredients
11/12/2009WO2009135858A1 Sialic acid to support the immune system in the elderly
11/12/2009WO2009135788A1 Heterocyclic antiviral compounds
11/12/2009WO2009135433A1 Use of total salvianolic acid, panax notoginsenosides and combination thereof in treating septicemia
11/12/2009WO2009117278A3 Processes for preparing (amino-pyrazolopyridinyl)methoxy substituted biaryl ethers
11/12/2009WO2009109531A3 Zn/trimethoprim combination therapy
11/12/2009WO2009108067A3 Fatty acid derivatives for use in the prevention and treatment of hsmi
11/12/2009WO2009105729A9 Immunogenic influenza composition
11/12/2009WO2009103035A3 Templated open flocs of anisotropic particles for enhanced pulmonary delivery
11/12/2009WO2009072007A3 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
11/12/2009WO2009069132A3 Novel reverse transcriptase inhibitors
11/12/2009WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009WO2007084435A8 Methods for treating hepatitis c
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281197 Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281141 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281140 Macrocyclic inhibitors of hepatitis c virus
11/12/2009US20090281133 Heterocyclic antiviral compounds
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281124 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
11/12/2009US20090281122 Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, and Compositions and Treatments Using the Same
11/12/2009US20090281094 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
11/12/2009US20090281088 N-{3-[3-Fluoro-4-(4-{2-[4-(2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yloxymethyl)-phenoxy]-acetyl}-piperazin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; for prevention and treatment of bacterial infections, caused by Mycobacterium tuberculosis
11/12/2009US20090281068 Polylactide compositions and uses thereof
11/12/2009US20090281054 Compositions and methods comprising capuramycin analogues
11/12/2009US20090281053 Novel crystalline form of lamivudine
11/12/2009US20090281052 Indole Antiviral Compositions And Methods
11/12/2009US20090281050 Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides
11/12/2009US20090281042 Compositions and methods using same for the detection of viruses
11/12/2009US20090281041 Antiviral cell-penetrating peptides
11/12/2009US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009US20090280144 Recombinant newcastle disease virus RNA expression systems and vaccines
11/12/2009US20090280141 Streptococcal Genes
11/12/2009US20090280140 assaying biological fluid sample from subject having symptoms of active tuberculosis for presence of early antibodies specific for a 27 kDa mycobacterial tuberculosis protein named MPT51
11/12/2009US20090280136 Immunization of fish with plant-expressed recombinant proteins
11/12/2009US20090280099 Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
11/12/2009US20090280098 Composition for beverage or food
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 1798